TürkçeLung cancer is primarily divided into two main groups: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). This classification is based on the microscopic structure of the tumor and its response to treatment. Each type differs in its course, rate of spread, and treatment strategy.
Small cell lung cancer is an aggressive type that grows rapidly and tends to metastasize early. It is generally directly associated with smoking, and most patients are diagnosed at an advanced stage. Chemotherapy and radiotherapy are the primary treatment options.
Non-small cell lung cancer accounts for approximately 85% of all lung cancers. It is divided into subtypes including adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Depending on the stage, treatment may include surgery, chemotherapy, radiotherapy, and targeted therapies.
Adenocarcinoma is the most common subtype among NSCLC types and is usually located in the outer regions of the lung. Squamous cell carcinoma develops more commonly in the large airways, whereas large cell carcinoma can occur in different areas throughout the lung. The course and treatment of each subtype differ.
Why Is Lung Cancer Classified?
Lung cancer is classified according to the appearance of the cells under a microscope. During the pathological examination, the structure of the cells in the tumor tissue, their growth rate, and their relationship with the surrounding tissues are evaluated. This classification helps to understand the behavior of the disease.
Patients often ask, “Which type is it?” after diagnosis. This is because some types progress more rapidly, while others may have a slower course. In addition, follow-up and treatment plans are shaped according to this classification. It is particularly emphasized that clinical decisions are determined not only by the type of cancer but also by the patient’s general health status and accompanying diseases.
Non-Small Cell Lung Cancer (NSCLC)
Non-small cell lung cancer accounts for the majority of lung cancer cases. This group is divided into different subtypes and generally tends to progress more slowly than the small cell type.
Patients diagnosed with NSCLC may state that their symptoms remained mild for a long time. Complaints such as cough, shortness of breath, or chest pain may gradually increase over time. Therefore, it may not always be possible to detect it at an early stage.
Adenocarcinoma
Adenocarcinoma is the most common subtype of non-small cell lung cancer. It develops from glandular cells located in the outer parts of the lung. The fact that it can also occur in non-smokers may be surprising for patients.
In this type, symptoms may sometimes be very subtle. It may be noticed through complaints such as a mild cough that does not go away for a long time or getting tired easily. The course of adenocarcinoma varies from person to person and requires specialist evaluation.
Squamous Cell Carcinoma
Squamous cell carcinoma generally originates from areas close to the airways. Its association with smoking is more pronounced. Therefore, patients may question their past habits when they receive the diagnosis.
Cough, coughing up blood, and chest pain are among the more commonly reported complaints in this type. Depending on the location of the tumor, difficulty breathing may also occur. However, the same symptoms are not expected to be seen in every patient.
Large Cell Carcinoma
Large cell carcinoma is a less common subtype. The appearance of the cells under the microscope differs from other types, and it may generally tend to grow more rapidly.
In this type, symptoms may become apparent within a short period. Fatigue, weight loss, and deterioration in general health may be among the complaints expressed by patients. Nevertheless, the diagnosis and follow-up process must always be planned individually.
Small Cell Lung Cancer (SCLC)
Small cell lung cancer is known as a more aggressive type. Although it accounts for a smaller proportion of lung cancers, it is evaluated under a separate heading due to its potential for rapid progression.
Patients diagnosed with this type may report that symptoms become apparent within a short period. Severe cough, shortness of breath, and rapid deterioration in general health may occur. Small cell lung cancer is frequently associated with smoking.
In this type, the likelihood of the disease spreading to other parts of the body at an early stage may be higher. Therefore, a comprehensive evaluation is performed during the diagnostic stage. The clinical approach is determined by considering the patient’s age and general condition.
Rarer Types of Lung Cancer
Although the main groups above usually come to mind when lung cancer is mentioned, there are also some rarer types. These types generally originate from different cell structures, and their course may vary.
Bronchial carcinoid tumors can be given as an example of this group. These tumors generally grow more slowly and may remain asymptomatic for a long time in some patients. Due to their rarity, the diagnostic process may sometimes be prolonged, and evaluation at experienced centers may be required.
Do the Symptoms of Lung Cancer Types Differ from Each Other?
Patients frequently ask, “Do the symptoms vary depending on the type?” Although there are some differences in symptoms among lung cancer types, many complaints are common. Persistent cough, shortness of breath, chest pain, and unexplained weight loss are among the most frequently reported complaints.
The severity and timing of symptoms vary depending on the location, size, and extent of spread of the tumor. Therefore, two patients with similar complaints may have completely different diagnoses and follow-up processes.
Why Is the Type Important During the Diagnostic Process?
Determining the type of lung cancer is one of the most critical stages of the diagnostic process. The information obtained from the pathological examination provides insight into the behavior of the disease. However, this information alone is not sufficient.
The patient’s general health status, age, and accompanying diseases are also taken into consideration. Specialist physicians evaluate all these data together and create a personalized roadmap. At this point, it is important for patients to try to understand the process and ask their questions without hesitation.
From the Patient’s Perspective
Learning about the types of lung cancer can increase patients’ sense of control. It is quite natural to experience uncertainty and anxiety after diagnosis. Knowing the name of the type and its general characteristics may help patients manage the process mentally.
However, it should not be forgotten that every case of lung cancer is unique. Information read on the internet or the experiences of others may not serve as a direct guide. Specialist evaluation is considered the most reliable reference at this point.
When Is Specialist Evaluation Necessary?
If symptoms such as a persistent cough, unexplained weight loss, or shortness of breath are present, it is recommended to seek specialist evaluation. These symptoms do not always indicate lung cancer; however, they require detailed assessment.
Having knowledge about the types of lung cancer increases awareness. It should be particularly emphasized that the steps taken during the diagnosis and follow-up process are personalized and that each patient’s condition is evaluated individually.
Frequently Asked Questions
Lung cancer is primarily divided into two main groups: small cell lung cancer and non-small cell lung cancer. The non-small cell type includes subtypes such as adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.
Small cell lung cancer tends to grow and spread more rapidly, whereas non-small cell lung cancer generally progresses more slowly. The treatment approach and course of the disease may vary depending on the type of cancer.
Persistent cough, shortness of breath, chest pain, bloody sputum, and weight loss may occur in many types of lung cancer. However, the severity and timing of symptoms may vary depending on the tumor type, location, and stage.
Diagnostic methods include chest X-ray, computed tomography, PET-CT, bronchoscopy, and biopsy. Pathological examination determines the type of cancer and helps establish the most appropriate treatment plan.
The treatment plan is prepared according to the cancer type, stage, molecular characteristics, and the patient’s general health status. Surgery, chemotherapy, radiotherapy, immunotherapy, and targeted therapies may be used alone or in combination in suitable patients.
Adenocarcinoma is the most common subtype of non-small cell lung cancer. It can develop in both smokers and non-smokers and generally originates from the outer regions of the lung.
Squamous cell carcinoma is mostly associated with smoking and generally develops in areas close to the large airways. In the early stages, it may cause symptoms related to cough, bloody sputum, and airway obstruction.
Small cell lung cancer is generally one of the fastest-growing and earliest-spreading types of lung cancer. Therefore, early diagnosis and prompt initiation of treatment are of great importance in disease management.
In some cases of non-small cell lung cancer, genetic alterations may affect treatment selection. Biomarker analyses help identify patients who are suitable for targeted therapies and immunotherapy.
Regardless of the type of lung cancer, early diagnosis may provide more treatment options and increase the likelihood of successful outcomes. Regular check-ups for individuals at risk and smoking cessation are of great importance.
Prof. Dr. Alper Fındıkcıoğlu graduated from Istanbul University Faculty of Medicine and completed his thoracic surgery residency at Dr. Siyami Ersek Hospital. He began his academic career at Başkent University in 2005; he received the title of associate professor in 2014 and professor in 2022. He has extensive experience in lung cancer, chest wall diseases, and minimally invasive surgery. Since 2024, he has been continuing his professional work at Acıbadem Hospital.
